Home » About Us » Team

Company

Acelot is a private company founded in 2006 using technology developed at UCSB that has been validated through multiple peer-reviewed publications. Headquartered in Santa Barbara, the company has received a number of SBIR grants from the National Institute of Health.

Core Team

ambuj_purple
Professor Ambuj K. Singh (President and CEO)
The founder of Acelot, Prof. Singh has authored over 140 scientific papers in the areas of bioinformatics, data mining, databases, and graph algorithms. He holds a Ph.D. from the University of Texas at Austin and a Bachelor's degree from the Indian Institute of Technology. He is currently a professor in the departments of Computer Science and Biomolecular Science & Engineering at the University of California, Santa Barbara. He works on developing the basic data and graph analysis methods that form the core IP of the company.
christian_purple
Christian A. Lang, Ph.D. (Chief Technology Officer)
Dr. Lang has extensive industry experience in research and productization of data mining and data management algorithms. He has successfully lead teams of researchers and software engineers, resulting in the development and delivery of innovative new features to well-known information management products such as IBM's flagship database DB2. He has published numerous peer reviewed papers in leading database and data mining conferences and journals and holds or has applied for more than 15 U.S. patents. Dr. Lang holds a Ph.D. degree (2003) in computer science from the University of California, Santa Barbara.
gilbert_purple
Gilbert M. Rishton, Ph.D. (Scientific Advisor)
Dr. Rishton is the Founder and Director of the Alzheimer's Institute at CSUCI. He has led drug discovery programs in pharma for over 15 years. During his years at Amgen, he was the founding medicinal chemist at the Thousand Oaks site. Dr. Rishton was responsible for much of the program initiation and group building for the Amgen Small Molecule Drug Discovery Group, which has grown to become one of the most formidable in the pharmaceutical industry. He has managed drug discovery programs in inflammation, oncology, and central nervous system disease.